Stabilization of Stannous pyrophosphate (cas 15578-26-4) kits with gentisic acid
-
Add time:08/29/2019 Source:sciencedirect.com
We evaluated the ability of gentisic acid, an antioxidant, to stabilize Stannous pyrophosphate (cas 15578-26-4) (Sn:PPi) kits and extend the shelf-life of the kit after reconstitution. In vitro studies showed that gentisic acid (0.5 mg/mL) stabilized the stannous ion against oxidation by various levels of exogenous hydrogen peroxide. In patients who received stabilized Sn:PPi for in vivo red blood cell labelling, the left ventricle-to-background activity ratio was significantly higher than that in patients who received a standard formulation of Sn:PPi. Gentisic acid is now used routinely in the Sn:PPi kit formulation in this institution.
We also recommend Trading Suppliers and Manufacturers of Stannous pyrophosphate (cas 15578-26-4). Pls Click Website Link as below: cas 15578-26-4 suppliers
Prev:Acidic properties of a clay prepared from the reaction of zirconyl chloride solution containing sulfate ions with montmorillonite
Next:Investigation of the interaction of hydroxyapatite with technetium in association with Stannous pyrophosphate (cas 15578-26-4)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Clinical studyPrognostic value of a persistently positive technetium-99m Stannous pyrophosphate (cas 15578-26-4) myocardial scintigram after myocardial infarction09/07/2019
- Experimental StudyMechanisms contributing to myocardial accumulation of technetium-99m Stannous pyrophosphate (cas 15578-26-4) after coronary arterial occlusion*09/06/2019
- Experimental and laboratory reportValue and limitations of technetium-99m Stannous pyrophosphate (cas 15578-26-4) in the detection of acute myocardial infarction☆09/05/2019
- Determination of the optimal concentrations of Stannous pyrophosphate (cas 15578-26-4) for in vivo red blood cell labelling with technetium-99m09/04/2019
- Experimental and laboratory reportTechnetium-99m Stannous pyrophosphate (cas 15578-26-4) myocardial scintigrams in pericardial disease☆09/03/2019
- NOTESStannous-Ion Quantitation in Pyrophosphate and Polyphosphate Radiopharmaceutical Kits Using Differential Pulse Polarography09/02/2019
- ReviewExploring the biological, catalytic, and magnetic properties of transition metal coordination complexes incorporating pyrophosphate09/01/2019
- Mechanistic aspects of the interaction of 99mTc in association with Stannous pyrophosphate (cas 15578-26-4) with damaged red blood cells08/31/2019
- Investigation of the interaction of hydroxyapatite with technetium in association with Stannous pyrophosphate (cas 15578-26-4)08/30/2019
-
Health and Chemical more >